The epidemiology of pneumococcal disease

This CPD challenge is designed to help you begin to build your knowledge and expertise in this area. It is imperative that as modern pharmacists we drive excellence in the care that we provide through the clinical services that we deliver for our patients.

We hope you share our ambition that every pharmacist should now actively be involved in prescribing activities tailored to the local population we serve.

Take your first step on your journey with us.


1. True or false, non-invasive pneumococcal disease in adults mainly causes community-acquired pneumonia?

Question 1 of 10

2. What is the annual incidence of community-acquired pneumonia in the adult population?

Question 2 of 10

3. What percentage of lower respiratory tract infections managed by GPs in the community can be attributed to community-acquired pneumonia?

Question 3 of 10

4. True or false, the overall annual incidence of invasive pneumococcal disease (IPD) in England and Wales is decreasing?

Question 4 of 10

5. True or false the recent increase in pneumococcal disease incidence increase is largely due to a considerable rise in IPD due to non-PCV13 serotypes, especially in adults aged 45 years and older?

Question 5 of 10

6. How many of the 10 most prevalent serotypes currently causing IPD are included in the 23-valent vaccine (PPV23)?

Question 6 of 10

7. True or false, IPD disproportionately affects young children and the elderly with rates higher than the overall rate?

Question 7 of 10

8. According to Public Health England in 2020 what was the incidence of IPD in children aged under 2 years per 100,000?


Question 8 of 10

9. True or false, 83% of cases of pneumococcal meningitis, occur in children aged under 2 years?

Question 9 of 10

10. True or false there is seasonal variation in IPD, with the highest incidence reported in winter?

Question 10 of 10


Published by

PIP editor

A pharmacist led training provider.

Leave a Reply

Your email address will not be published.